Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 28, 2017
Pharmacy Choice - News - Generic Drugs - May 28, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

4/28/17 - Amneal Introduces Its First Nasal Spray: Generic Nasonex
By a News Reporter-Staff News Editor at Drug Week- HYPERLINK " https://amneal.com/"\ nAmneal Pharmaceuticals LLC has launched mometasone furoate nasal spray, the company's first pharmaceutical product in spray form. Manufactured in Branchburg, NJ, the product began shipping April 4th through wholesalers, distributors and directly to the trade.
4/28/17 - ANDA approval times should be cut by two-thirds [Syrian Arab News Agency]
Girish Malhotra, President of EPCOT International, and CPhI Worldwide Annual Industry Report member, discusses the necessity of time reduction for Abbreviated New Drug Application approvals. This time can potentially be reduced to 15 days if the FDA modifies their review process. To avoid confusion, the FDA would have to create applications that cl
4/28/17 - Bharat Book Bureau: Brazil Generic Drug Market: Industry Trends
Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. The report entitled "Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022" represents an in-depth analysis on the historical, current and future trends
4/28/17 - Bharat Book Bureau: Canada Generic Drug Market Industry Trends
Canada represents the world's ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors.
4/28/17 - Bharat Book Bureau: Canada Generic Drug Market: Industry Trends
Canada represents the world's ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors.
4/28/17 - Bharat Book Bureau: Global Biopharmaceutical Market Report
The global biopharmaceutical Industry has come a long way since its first drug- Humulin was approved in 1982. Today hundreds of biopharmaceuticals have already been approved and many more are in late stages of clinical development. Although factors like biosimilar entry and cost containment in the developed markets are likely to restrain the growth
4/28/17 - Bharat Book Bureau: Japan Generic Drug Market: Industry Trends
Japan represents the world's eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe. Generic drugs also remained less popular in Japan because of the lack of generic substitution rig
4/28/17 - Bharat Book Bureau: US Generic Drug Market: Industry Trends
The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. The report entitled "US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2
4/28/17 - Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars
"Emerging economies such as India, Latin America, and South Korea are establishing large manufacturing hubs for biosimilars. Global Biopharmaceutical Analytical Instrumentation Market, Forecast to 2022, recent analysis from Frost& Sullivan's HYPERLINK " http://ww2.frost.com/research/industry/measurement-instrumentation/test-measurement"\...
4/28/17 - Determination That DEMEROL (Meperidine Hydrochloride) Injectable and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or...
Notice. Citation: "82 FR 19735" Document Number: "Docket No. FDA-2017-N-1551" Page Number: "19735" "Notices" SUMMARY: The Food and Drug Administration (FDA or Agency) has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin pro
4/28/17 - DR REDDY'S VYTORIN GENERIC IN US
Indian Pharmaceutical giant Dr Reddy's Laboratories Limited has launched. It is a therapeutic equivalent of generic version of Vytorin tablets, of MSD International GmbH. IMS Health sales of Vytorin brand in US was about $678 million for the 12 months ended in Feb 2017.
4/28/17 - Europe Biosimilars Market 2017-2025: 30 Companies are Actively Developing Biosimilar Medicines With 8 Major Biologic Medicines Expected to Lose Exclusivity by 2020 - Research and Markets
Research and Markets has announced the addition of the " Europe: Biosimilars Market- Forecast to 2025" report to their offering. The study analyzes the supply market dynamics and forecasts future revenues for key biosimilars in the European region. By assessing the impact of trends, disruptive technologies, and new business models, the study arri
4/28/17 - Franken, constituents talk high drug costs [The Pine Journal, Cloquet, Minn.]
April 28 U.S. Senator Al Franken visited Gordy's Warming House Thursday not for the ice cream or the coffee, but rather to meet with a group of Northland residents who are on the front lines of the battle against the high cost of pharmaceuticals in the United States. The goal of the bill is to reduce barriers that currently prevent Medicare from
4/28/17 - Klobuchar, Leaders of Senate and House Judiciary Committees Introduce Bipartisan Legislation to Counter Rising Prescription Drug Prices
Amy Klobuchar, D- Minn., issued the following news release:. U.S. Senator Amy Klobuchar and top leaders on the Senate and House Judiciary Committees introduced legislation to combat anticompetitive practices used by some brand-name pharmaceutical and biologic companies to block entry of lower-cost generic drugs. The bill is sponsored by Senator Pat
4/28/17 - Leaders of Senate and House Judiciary Committees Reintroduce Bipartisan Legislation to Counter Rising Prescription Drug Prices
Top leaders on the Senate and House Judiciary Committees led by Senator Patrick Leahy on Thursday introduced legislation to combat anticompetitive practices used by some brand-name pharmaceutical and biologic companies to block entry of lower-cost generic drugs. The bill is sponsored by Leahy and cosponsored by Chairman Chuck Grassley, Ranking Memb
4/28/17 - Lupin receives USFDA approval for generic Benicar tablets [India Infoline News Service]
Pharma major, Lupin Limited, on Friday announced that it has received final approval for its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg from the United States Food and Drug Administration, to market generic version of Benicar tablets, 5 mg, 20 mg and 40 mg. Pharma major, Lupin Limited, on Friday announced that it has received final approva
4/28/17 - Partial Settlement of a Class Action Lawsuit for Purchasers of Solodyn and/or Its Generic Equivalent is Announced
The lawsuit claims that Medicis Pharmaceutical Corp., Valeant Pharmaceuticals International, Inc., Impax Laboratories, Inc., Lupin Limited, Lupin Pharmaceuticals Inc., and Sandoz Inc. violated state competition and unjust enrichment laws by agreeing not to compete with each other and keeping lower-cost generic versions of Solodyn off the market.
4/28/17 - Purchase Along With The Delivery Of Oncological Drugs, Generic Drugs And Nutrition For The Hospital Pharmacy Of The Swietokrzyskie Center Of Oncology In Kielce. [TendersInfo (India)]
Contract notice: Purchase along with the delivery of oncological drugs, generic drugs and nutrition for the hospital pharmacy of the Swietokrzyskie center of oncology in kielce. Detailed description of the object of the order together with specification of assortment, quantity and quality requirements falling within the scope of the subject of...
4/28/17 - Rep. Cicilline, Sen. Leahy Announce Bipartisan Bill to Lower Prescription Drug Costs
David N. Cicilline, D- R.I., issued the following news release:. U.S. Congressman David N. Cicilline and U.S. Senator Patrick Leahy today announced the introduction of legislation to combat anticompetitive practices used by some brand-name pharmaceutical and biologic companies to block entry of lower-cost generic drugs. Cicilline is also being join
4/28/17 - Rep. Marino Introduces Bill to Facilitate Lower-Cost Generic Drugs Entry
Tom Marino, R- Pa., has introduced legislation to "promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products." Tom Marino in Washington at 2242 Rayburn House Office Building, Washington, DC 20515; 202/ 225-3731; or in the
4/28/17 - Xbrane Biopharma publishes 2016 annual report
The annual report can also be ordered from Xbrane Biopharma on the following adress: Xbrane Biopharma AB Banvaktsvgen 22 17148 Solna Sweden Or via e-mail: ir@xbrane.com Xbrane Biopharma is a biotechnology company in the commercial phase which develops and manufactures biosimilars and generic long-acting injectables. Xbrane's head office is locate
4/27/17 - ALKERMES PLC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Executive Summary Net loss for the three months ended March 31, 2017 was $68.9 million, or $0.45 per ordinary share- basic and diluted, as compared to a net loss of $77.4 million, or $0.51 per ordinary share- basic and diluted for the three months ended March 31, 2016. The decrease in the net loss incurred in the three months ended March 31, 2017,
4/27/17 - ANALYSE THIS...Leigh Khler Head of research at Glacier by Sanlam
Head of research at Glacier by Sanlam. As one of the top 10 largest generic drug producers in the world, Aspen is well-positioned to provide for a growing population especially in developing markets. Aspen buys companies aligned to its strategic focus and aims to own the entire value chain.
4/27/17 - Biosimilars Market, Europe, Forecast to 2025
Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with population aging in Europe. Download the full report: https://www.reportbuyer.com/product/4842294/ Moreover, patent expiry of key product classes and a growing emphasis on cost effectiveness are making...
4/27/17 - Cancer Supportive Care Market Worth USD12.4 Billion in 2022 from USD11.7 Billion in 2015
NEW YORK, April 27, 2017/ PRNewswire-iReach/ ReportsnReports.com published the report "Global Cancer Supportive Care Therapeutics Market to 2022- Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets" provides an introduction to key indications within cancer supportive care, including..
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415